Citation 106438

ASANO,N: NISHIDA,M: KATO,A: KIZU,H: MATSUI,K: SHIMADA,Y: ITOH,T: BABA,M: WATSON,AA: NASH,RJ: DE Q LILLEY,PM: WATKIN,DJ: FLEET,GWJ:. (1998). HOMONOJIRIMYCIN ISOMERS AND N-ALKYLATED HOMONOJIRIMYCINS: STRUCTURAL AND CONFORMATIONAL BASIS OF INHIBITION OF GLYCOSIDASES.. 41(14)

Citation Details

Title	HOMONOJIRIMYCIN ISOMERS AND N-ALKYLATED HOMONOJIRIMYCINS: STRUCTURAL AND CONFORMATIONAL BASIS OF INHIBITION OF GLYCOSIDASES.
Authors	ASANO,N: NISHIDA,M: KATO,A: KIZU,H: MATSUI,K: SHIMADA,Y: ITOH,T: BABA,M: WATSON,AA: NASH,RJ: DE Q LILLEY,PM: WATKIN,DJ: FLEET,GWJ:
Year	1998
Volume	41
Issue	14

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	STRONG ACTIVITY
2	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	ACTIVE
3	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	ACTIVE
4	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	ACTIVE
5	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	WEAK ACTIVITY
6	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
7	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
8	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
9	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
10	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
11	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	WEAK ACTIVITY
12	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	WEAK ACTIVITY
13	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	WEAK ACTIVITY
14	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	WEAK ACTIVITY
15	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	INACTIVE
16	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	INACTIVE
17	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	INACTIVE
18	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	INACTIVE
19	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	INACTIVE
20	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-HOMO:	INACTIVE
21	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
22	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	WEAK ACTIVITY
23	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	WEAK ACTIVITY
24	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
25	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
26	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
27	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
28	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	INACTIVE
29	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	WEAK ACTIVITY
30	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,ALPHA-HOMO:	WEAK ACTIVITY
31	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	ACTIVE
32	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	ACTIVE
33	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	ACTIVE
34	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	ACTIVE
35	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	INACTIVE
36	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	INACTIVE
37	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	INACTIVE
38	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	INACTIVE
39	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	ACTIVE
40	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNONOJIRIMYCIN,BETA-HOMO:	ACTIVE
41	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
42	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
43	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
44	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
45	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
46	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	WEAK ACTIVITY
47	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
48	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
49	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
50	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,HOMO: ALPHA-3-4-DI-EPI:	INACTIVE
51	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	ACTIVE
52	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	ACTIVE
53	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	ACTIVE
54	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	ACTIVE
55	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	INACTIVE
56	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	WEAK ACTIVITY
57	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	WEAK ACTIVITY
58	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	INACTIVE
59	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	WEAK ACTIVITY
60	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOJIRIMYCIN,BETA-4-5-DI-EPI:	WEAK ACTIVITY

Citation 106438

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1